These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 34493602)

  • 1. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
    Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
    Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites.
    Nasrin S; Watson CJW; Bardhi K; Fort G; Chen G; Lazarus P
    Drug Metab Dispos; 2021 Dec; 49(12):1081-1089. PubMed ID: 34493601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites.
    Qian Y; Wang X; Markowitz JS
    Drug Metab Dispos; 2019 May; 47(5):465-472. PubMed ID: 30833288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes.
    Bansal S; Paine MF; Unadkat JD
    Drug Metab Dispos; 2022 Apr; 50(4):351-360. PubMed ID: 35115300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications.
    Qian Y; Gurley BJ; Markowitz JS
    J Clin Psychopharmacol; 2019; 39(5):462-471. PubMed ID: 31433338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
    Bansal S; Zamarripa CA; Spindle TR; Weerts EM; Thummel KE; Vandrey R; Paine MF; Unadkat JD
    Clin Pharmacol Ther; 2023 Sep; 114(3):693-703. PubMed ID: 37313955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization.
    Doohan PT; Oldfield LD; Arnold JC; Anderson LL
    AAPS J; 2021 Jun; 23(4):91. PubMed ID: 34181150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450.
    Bansal S; Maharao N; Paine MF; Unadkat JD
    Drug Metab Dispos; 2020 Oct; 48(10):1008-1017. PubMed ID: 32587099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
    Yamaori S; Koeda K; Kushihara M; Hada Y; Yamamoto I; Watanabe K
    Drug Metab Pharmacokinet; 2012; 27(3):294-300. PubMed ID: 22166891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids.
    Mazur A; Lichti CF; Prather PL; Zielinska AK; Bratton SM; Gallus-Zawada A; Finel M; Miller GP; Radomińska-Pandya A; Moran JH
    Drug Metab Dispos; 2009 Jul; 37(7):1496-504. PubMed ID: 19339377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabidiol and Δ
    Smith SA; Le GH; Teopiz KM; Kwan ATH; Rhee TG; Ho RC; Wu J; Cao B; Ceban F; McIntyre RS
    Drug Metab Rev; 2024; 56(2):164-174. PubMed ID: 38655747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.
    Watanabe K; Yamaori S; Funahashi T; Kimura T; Yamamoto I
    Life Sci; 2007 Mar; 80(15):1415-9. PubMed ID: 17303175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid-Induced Inhibition of Morphine Glucuronidation and the Potential for In Vivo Drug-Drug Interactions.
    Coates S; Bardhi K; Lazarus P
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
    Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of in vivo liver metabolites of delta 1-tetra-hydrocannabinol, cannabidiol, and cannabinol produced by the guninea-pig.
    Harvey DJ; Martin BR; Paton WD
    J Pharm Pharmacol; 1980 Apr; 32(4):267-71. PubMed ID: 6103056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properties of UDP-glucuronyltransferase for cannabinoids in rat liver microsomes.
    Watanabe K; Kita M; Yamamoto I; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1983 Aug; 6(8):581-7. PubMed ID: 6315914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
    Alozie SO; Martin BR; Harris LS; Dewey WL
    Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.
    Stout SM; Cimino NM
    Drug Metab Rev; 2014 Feb; 46(1):86-95. PubMed ID: 24160757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of cannabinoids with bovine serum albumin.
    Haque SJ; Poddar MK
    Biosci Rep; 1984 Mar; 4(3):239-43. PubMed ID: 6326885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Enzymes Relevant to the Disposition of (-)-∆
    Patilea-Vrana GI; Anoshchenko O; Unadkat JD
    Drug Metab Dispos; 2019 Mar; 47(3):249-256. PubMed ID: 30567877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.